Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Shimpei Matsui"'
Autor:
Kimihiko Nakamura, Ryo Seishima, Shimpei Matsui, Kohei Shigeta, Koji Okabayashi, Yuko Kitagawa
Publikováno v:
Annals of Gastroenterological Surgery, Vol 8, Iss 4, Pp 650-659 (2024)
Abstract Aim Serum cholinesterase (ChE) levels are considered to reflect nutritional status. Although ChE has been well documented as a prognostic factor for some cancers, no clear consensus on its use for colorectal cancer (CRC) has been reached. Th
Externí odkaz:
https://doaj.org/article/387b258f885842d59e82ae4b8a8b25ad
Autor:
Koji Okabayashi, Eiji Shinozaki, Kensei Yamaguchi, Tomohiro Yamaguchi, Naoki Ishizuka, Tsuyoshi Konishi, Takashi Akiyoshi, Senzo Taguchi, Akiko Chino, Makiko Hiratsuka, Tetsuro Tominaga, Takashi Nonaka, Shigeo Toda, Shuichiro Matoba, Shimpei Matsui, Toshiki Mukai, Yukiharu Hiyoshi, Toshiya Nagasaki, Masashi Ueno, Hiroya Kuroyanagi, Yosuke Fukunaga
Publikováno v:
BMJ Open, Vol 12, Iss 3 (2022)
Introduction Total mesorectal excision (TME) and postoperative adjuvant chemotherapy following neoadjuvant chemoradiotherapy (CRT) is the standard treatment for locally advanced rectal cancer (LARC). However, neoadjuvant CRT has no recognised impact
Externí odkaz:
https://doaj.org/article/786e4de805d94db59f550d25722e5c49
Autor:
Tatsuo Matsuda, Eisaku Miyauchi, Yu-Wen Hsu, Satoshi Nagayama, Kazuma Kiyotani, Makda Zewde, Jae-Hyun Park, Taigo Kato, Makiko Harada, Shimpei Matsui, Masashi Ueno, Kazumasa Fukuda, Nobuaki Suzuki, Shoichi Hazama, Hiroaki Nagano, Hiroya Takeuchi, Wickii T. Vigneswaran, Yuko Kitagawa, Yusuke Nakamura
Publikováno v:
OncoImmunology, Vol 8, Iss 6 (2019)
Tumor draining lymph nodes (TDLNs) are located in the routes of lymphatic drainage from a primary tumor and have the highest risk of metastasis in various types of solid tumors. TDLNs are also considered as a tissue to activate the antitumor immunity
Externí odkaz:
https://doaj.org/article/4d5272f00a2b47c0914c3af80234fb2d
Autor:
Kyoko Sakamoto, Koji Okabayashi, Shimpei Matsui, Ryo Seishima, Kohei Shigeta, Yohei Masugi, Yuko Kitagawa
Publikováno v:
The Japanese Journal of Gastroenterological Surgery. 56:214-220
Autor:
Kiyoaki Sugiura, Yuki Seo, Yuki Tajima, Hiroto Kikuchi, Akira Hirata, Jumpei Nakadai, Hideo Baba, Takayuki Kondo, Akitsugu Makino, Yujin Kato, Shimpei Matsui, Ryo Seishima, Kohei Shigeta, Koji Okabayashi, Yuko Kitagawa
Publikováno v:
World Journal of Surgery. 47:1292-1302
Publikováno v:
ANZ Journal of Surgery. 93:1257-1261
The number of lymph node metastasis (LNM) is a strong prognostic factor in the treatment of colorectal cancer (CRC). However, the impact of the mesentery location on LNM remains unclear. We assessed the impact LNM location on the recurrence of stage
Publikováno v:
Journal of Gastrointestinal Surgery. 26:2227-2236
Metformin has been reported to be associated with improved cancer prognosis when used in combination with chemotherapy and/or radiotherapy. In this study, we present a systematic review and meta-analyses of studies evaluating the association of tumor
Autor:
Kyoko Sakamoto, Koji Okabayashi, Shunsuke Matsumoto, Shimpei Matsui, Ryo Seishima, Kohei Shigeta, Yuko Kitagawa
Publikováno v:
Colorectal Disease.
Autor:
Kimihiko Nakamura, Ryo Seishima, Shimpei Matsui, Kohei Shigeta, Koji Okabayashi, Yuko Kitagawa
Publikováno v:
Japanese Journal of Clinical Oncology. 52:562-570
Objective The relationship between preoperative mean corpuscular volume and postoperative prognosis has been reported in some cancers recently, but no certain consensus has been reached, especially for colorectal cancer. We evaluated the usefulness o
Autor:
TAKETO SASAKI, KOHEI SHIGETA, SHUJI KITAHARA, YASUHIRO SUZUKI, SHIMPEI MATSUI, RYO SEISHIMA, KOJI OKABAYASHI, DAN G. DUDA, YUKO KITAGAWA
Publikováno v:
Anticancer research. 42(11)
STAT3 is involved in the progression of several cancers, and has been proposed as target for therapy. Indeed, the multitargeted tyrosine kinase inhibitor drug regorafenib, which indirectly inhibits STAT3, can significantly enhance the effects of anti